Welcure Drugs & Pharmaceuticals Ltd Share Price

8.07
(0.00%)
Dec 2, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open8.07
  • Day's High8.07
  • 52 Wk High8.07
  • Prev. Close8.07
  • Day's Low8.07
  • 52 Wk Low 3.76
  • Turnover (lac)1.8
  • P/E62.08
  • Face Value10
  • Book Value9.05
  • EPS0.13
  • Mkt. Cap (Cr.)90.8
  • Div. Yield0
View All Historical Data
No Records Found

Welcure Drugs & Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

8.07

Prev. Close

8.07

Turnover(Lac.)

1.8

Day's High

8.07

Day's Low

8.07

52 Week's High

8.07

52 Week's Low

3.76

Book Value

9.05

Face Value

10

Mkt Cap (₹ Cr.)

90.8

P/E

62.08

EPS

0.13

Divi. Yield

0

Welcure Drugs & Pharmaceuticals Ltd Corporate Action

9 Sep 2024

12:00 AM

AGM

Announcement Date: 09 Sep, 2024

arrow

9 Sep 2024

12:00 AM

BookCloser

arrow

2 Dec 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Welcure Drugs & Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Welcure Drugs & Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

07 Dec, 2024|02:36 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.00%

Foreign: 0.00%

Indian: 0.00%

Non-Promoter- 1000.00%

Institutions: 0.00%

Non-Institutions: 100.00%

Custodian: 0.00%

Share Price

Welcure Drugs & Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

13.44

13.44

12.12

12.12

Preference Capital

0

0

0

0

Reserves

-12.1

-11.92

-12.03

-12.05

Net Worth

1.34

1.52

0.08

0.06

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

0.1

0.13

0.08

0.05

yoy growth (%)

-21.23

61.57

65

-44.19

Raw materials

0

0

0

0

As % of sales

0

0

0

0

Employee costs

-0.01

0

0

0

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

0.02

0.05

0

-0.01

Depreciation

0

0

0

0

Tax paid

0

0

0

0

Working capital

0.02

0.03

-0.01

-0.02

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-21.23

61.57

65

-44.19

Op profit growth

-57.05

-661.27

-52.28

-174.27

EBIT growth

-57.2

-684.21

-51.13

-169.92

Net profit growth

-57.2

-684.21

-51.13

-169.92

View Ratios

No Record Found

Welcure Drugs & Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,804.8

157.54,34,195.65863.290.755,123.6798.33

Divis Laboratories Ltd

DIVISLAB

6,130.1

88.091,61,829.655180.492,302513.62

Cipla Ltd

CIPLA

1,477.6

28.591,21,053.041,178.160.873,969.86360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,332.25

69.571,13,812.44600.832,376222.38

Mankind Pharma Ltd

MANKIND

2,585.1

52.351,04,937.42634.4302,529.74269.23

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Welcure Drugs & Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Non-Exec. & Independent Dir.

Gagan Juneja

Independent Director

Mohd. Shahbaz Alam

Additional Director

Sitaben S Patel

Additional Director

Rajeev Mehra

Managing Director

Vishal Mehra

Company Sec. & Compli. Officer

Manowar Ali

Additional Director

Pradeep Dnyaneshwar Terse

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Welcure Drugs & Pharmaceuticals Ltd

Summary

Incorporated on 4 Jun.92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.96 to finance its expansion programmes.Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market.The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, S
Read More

Company FAQs

What is the Welcure Drugs & Pharmaceuticals Ltd share price today?

The Welcure Drugs & Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹8.07 today.

What is the Market Cap of Welcure Drugs & Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Welcure Drugs & Pharmaceuticals Ltd is ₹90.80 Cr. as of 02 Dec ‘24

What is the PE and PB ratio of Welcure Drugs & Pharmaceuticals Ltd?

The PE and PB ratios of Welcure Drugs & Pharmaceuticals Ltd is 62.08 and 0.89 as of 02 Dec ‘24

What is the 52 Week High and Low of Welcure Drugs & Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Welcure Drugs & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Welcure Drugs & Pharmaceuticals Ltd is ₹3.76 and ₹8.07 as of 02 Dec ‘24

What is the CAGR of Welcure Drugs & Pharmaceuticals Ltd?

Welcure Drugs & Pharmaceuticals Ltd's CAGR for 5 Years at 69.31%, 3 Years at -1.33%, 1 Year at 102.76%, 6 Month at 78.54%, 3 Month at 10.10% and 1 Month at 4.94%.

What is the shareholding pattern of Welcure Drugs & Pharmaceuticals Ltd?

The shareholding pattern of Welcure Drugs & Pharmaceuticals Ltd is as follows:
Promoters - 0.00 %
Institutions - 0.00 %
Public - 100.00 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp